Probenecid Tablet USP 500 mg

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Probenecid Tablet USP 500 mg contains probenecid, a uricosuric agent. Its labelling describes it for the long-term management of gout and gouty arthritis by increasing the amount of uric acid the kidneys remove from the body, which is described as helping to prevent gout attacks and certain types of kidney stone. It is described as not intended for the treatment of an acute gout attack.

Active ingredient
Probenecid
Strength
500 mg
Dosage form
Oral tablet (USP)
Therapeutic class
Uricosuric agent (anti-gout)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with probenecid and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for the long-term management of gout and gouty arthritis
  • Described as increasing the removal of uric acid by the kidneys, which is described as helping to prevent gout attacks and certain kidney stones
  • Described as not intended for the treatment of an acute gout attack
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Taken by mouth at the dose and duration set by the doctor
  • An adequate amount of water should be taken with the medicine
  • It should not be used together with salicylates such as aspirin

Described Side Effects

Commonly described side effects include:

  • Nausea and vomiting
  • Headache
  • Gout flares
  • Fever
  • Rash
  • Blood disorders such as aplastic anaemia, haemolytic anaemia, or a decreased white blood cell (lymphocyte) count

Blood disorders are described as uncommon but serious and require prompt medical attention. Any severe, persistent, or unexpected reaction requires prompt medical attention.

Precautions

  • It should not be used with salicylates such as aspirin
  • The doctor should be told about all current medicines being taken
  • An adequate fluid intake should be maintained during treatment
  • The doctor should be informed if the patient is pregnant or breastfeeding; the medicine is described as causing dizziness, so driving and tasks needing focus should be avoided

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it contains probenecid, a uricosuric agent used for the long-term management of gout and gouty arthritis by increasing the removal of uric acid by the kidneys. It is described as not for the treatment of an acute gout attack. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling describes it as taken by mouth at the dose and duration set by the doctor, with an adequate amount of water, and not together with salicylates such as aspirin.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services